Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathophysiology of stroke.

S Strandgaard1, O B Paulson

  • 1Department of Medicine and Nephrology B, Herlev Hospital, Copenhagen, Denmark.

Journal of Cardiovascular Pharmacology
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of electroconvulsive therapy on neural response to affective pictures: A randomized, sham-controlled fMRI study.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2018
Same author

Effects of erythropoietin on memory-relevant neurocircuitry activity and recall in mood disorders.

Acta psychiatrica Scandinavica·2016
Same author

Neural correlates of improved executive function following erythropoietin treatment in mood disorders.

Psychological medicine·2016
Same author

Regional brain volumes, diffusivity, and metabolite changes after electroconvulsive therapy for severe depression.

Acta psychiatrica Scandinavica·2015
Same author

Cognitive profiles and regional cerebral blood flow patterns in dementia of the Alzheimer type.

European journal of neurology·2013
Same author

Altered reward processing in the orbitofrontal cortex and hippocampus in healthy first-degree relatives of patients with depression.

Psychological medicine·2013
Same journal

Integration of Mendelian Randomization and FAERS Database Analysis Reveals the Association Between Ergotamine and Aortic and Mitral Valve Diseases.

Journal of cardiovascular pharmacology·2026
Same journal

A Comprehensive Review of PCSK9 Inhibitor Therapy.

Journal of cardiovascular pharmacology·2026
Same journal

SGLT2 Inhibitors and Progression of Chronic Kidney Disease in Patients with Elevated Lipoprotein(a): A Real-World Cohort Study.

Journal of cardiovascular pharmacology·2026
Same journal

Aspirin in primary prevention: a case for selective use.

Journal of cardiovascular pharmacology·2026
Same journal

GLP-1 Gene Therapy Trial for Obesity and Type 2 Diabetes: Towards a New Paradigm for Chronic Disease Treatment.

Journal of cardiovascular pharmacology·2026
Same journal

Expert Opinion: Restrictions, Precautions, or Normalcy? Defining Everyday Risk in Patients Treated With IL-1 Blockers for Recurrent Pericarditis.

Journal of cardiovascular pharmacology·2026
See all related articles

Timely intervention is crucial for salvaging viable brain tissue in acute ischemic stroke. Vasoconstrictors and converting-enzyme inhibitors show potential, while calcium antagonists may improve outcomes by protecting threatened brain cells.

Area of Science:

  • Neurology
  • Cerebrovascular Medicine

Background:

  • Acute ischemic stroke requires immediate intervention to preserve viable brain tissue.
  • Chronic threatening ischemia involves viable tissue with compromised collateral circulation.
  • Cerebral vasomotor dysfunction is characteristic of both acute and chronic ischemic conditions.

Purpose of the Study:

  • To review therapeutic strategies for acute ischemic stroke and chronic threatening ischemia.
  • To evaluate the effects of vasodilators, vasoconstrictors, converting-enzyme inhibitors, and calcium antagonists on cerebral perfusion and patient outcomes.

Main Methods:

  • Review of existing literature on cerebrovascular physiology and stroke therapeutics.
  • Analysis of the impact of different drug classes on cerebral blood flow and autoregulation.

Related Experiment Videos

  • Examination of clinical trial data regarding stroke patient outcomes.

    • Main Results:

    • Vasodilators may worsen perfusion in ischemic areas by "stealing" blood.
    • Vasoconstrictors might improve perfusion in ischemic tissue but have shown limited clinical benefit.
    • Converting-enzyme inhibitors may favorably alter cerebral autoregulation.
    • Calcium antagonists, despite potential "steal" effects, show promise in improving stroke patient outcomes.

    Conclusions:

    • Therapeutic strategies must consider the unique pathophysiology of acute and chronic ischemic conditions.
    • Targeting ischemia-threatened brain cells, potentially with calcium antagonists, may be a viable approach.
    • Further research is needed to optimize pharmacological interventions for stroke management.